Jr Stephen M Ward
CIK 1164644 · last filed 2026-10-15
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
AI price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
PO BOX 14662
READING, PA 19612
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CXM | Director | 237,088 | $6.42 | $1.52M | $850.5K | 4 | 2026-10-15 |
| CRS | Director | 29,276 | $368.16 | $10.78M | -$881.9K | 33 | 2026-10-14 |
| AI | Director | 588,877 | $11.79 | $6.94M | -$27.93M | 13 | 2025-10-07 |
| Molekule Group, Inc. (AERC) Delisted | Director | — | $3.40 | — | $0 | 1 | 2022-11-14 |
| VG | Director | 0 | $12.85 | $0 | $0 | 2 | 2022-07-21 |
| KLXE | Director | 7,907 | $1.16 | $9.2K | $0 | 2 | 2021-03-09 |
| KLX Inc. (KLXI) Delisted | Director | 13,952 | — | — | $0 | 13 | 2018-08-02 |
Recent Filings · Page 3 of 8
74 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-05-30 | AI | Notice (144) | −120,000 | -$5.04M | EDGAR |
| 2022-11-14 | Molekule Group, Inc. (AERC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-10-13 | CRS | Grant (A) | — | $0 | EDGAR |
| 2022-10-07 | AI | Grant (A) | — | $0 | EDGAR |
| 2022-09-29 | AI | Mixed | +66,406 | -$282 | EDGAR |
| 2022-07-21 | VG | Disp (D) | −4,312 | -$90.6K | EDGAR |
| 2021-10-14 | CRS | Grant (A) | — | $0 | EDGAR |
| 2021-10-08 | AI | Grant (A) | — | $0 | EDGAR |
| 2021-10-05 | VG | Grant (A) | +1,753 | $0 | EDGAR |
| 2021-07-06 | AI | Mixed | −10,468 | -$1.24M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.